SCHEMBL26750022

SCHEMBL26750022

COCCCOc1ccc(C(C)(C)c2cc(Cl)c(OCC(CCl)OC(C)=O)c(Cl)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 3/20 0.60
▸ KDM4E B2RXH2 9/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ PPARD Q03181 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ HTT P42858 3/20 0.36
▸ POLB P06746 2/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ ACACB O00763 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19460068 0.92 AR (0.68) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL19460212 0.92 AR (0.68) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL19484410 0.92 AR (0.68) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL19460134 0.92 AR (0.68) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL19460141 0.92 AR (0.68) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL19460029 0.92 AR (0.68) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL26749535 0.91 AR (0.61) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL26750384 0.90 AR (0.58) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL26750635 0.90 AR (0.60) ARKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL19482555 0.89 AR (0.61) ARKDM4EALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3442942-B1 BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2023-11-15 — — EP disclosed
Send feedback